Comparison of the inhibitory activities of human tissue factor pathway inhibitor (TFPI)a and TFPIß

Background: Tissue factor pathway inhibitor (TFPI) is an alternatively spliced protein with two isoforms, TFPIa and TFPIß, which differ in their C-terminal structure and cellular localization. Detailed characterization of their inhibitory activity is needed to define potentially unique inhibitory ro...

Full description

Bibliographic Details
Main Authors: Maroney, S., Ellery, Paul, Wood, J., Ferrel, J., Martinez, N., Mast, A.
Format: Journal Article
Published: 2013
Online Access:http://hdl.handle.net/20.500.11937/18059
_version_ 1848749635964764160
author Maroney, S.
Ellery, Paul
Wood, J.
Ferrel, J.
Martinez, N.
Mast, A.
author_facet Maroney, S.
Ellery, Paul
Wood, J.
Ferrel, J.
Martinez, N.
Mast, A.
author_sort Maroney, S.
building Curtin Institutional Repository
collection Online Access
description Background: Tissue factor pathway inhibitor (TFPI) is an alternatively spliced protein with two isoforms, TFPIa and TFPIß, which differ in their C-terminal structure and cellular localization. Detailed characterization of their inhibitory activity is needed to define potentially unique inhibitory roles in tissue factor (TF)-mediated thrombotic and inflammatory disease, and to understand how pharmaceuticals targeted to different structural regions of the TFPI isoforms alter hemostasis in hemophilia patients. Methods: The TF inhibitory activity of TFPIß localized to the surface of CHO cells was compared with that of soluble TFPIa by the use of in vitro and in vivo assays. Results: In TF-factor VIIa-mediated FXa generation assays, TFPIß was a slightly better inhibitor than TFPIa, which was approximately three-fold better than TFPI-160, a soluble, altered form of TFPI similar to TFPIß. In direct FXa inhibitory assays, TFPIß had an IC50 2.5-fold lower than that of TFPIa and 56-fold lower than that of TFPI-160. TFPIß inhibited TF-mediated CHO cell migration though Matrigel, whereas TFPIa and TFPI-160 were poor inhibitors, demonstrating that TFPIß effectively blocks TF-initiated signaling events during cellular migration through matrices that are not permeable to soluble forms of TFPI. Furthermore, TFPIß inhibited TF-dependent CHO cell infiltration into lung tissue following tail vein injection into SCID mice, and blocked the development of consumptive coagulopathy. Conclusions: TFPIß is a slightly better inhibitor of TF procoagulant activity than TFPIa. As a surface-associated protein, TFPIß is a much better inhibitor of TF-mediated cellular migration than soluble TFPIa, and may specifically act in the inhibition of TF-mediated signaling events on inflamed endothelium and/or monocytes. © 2013 International Society on Thrombosis and Haemostasis.
first_indexed 2025-11-14T07:24:05Z
format Journal Article
id curtin-20.500.11937-18059
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T07:24:05Z
publishDate 2013
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-180592017-09-13T15:42:02Z Comparison of the inhibitory activities of human tissue factor pathway inhibitor (TFPI)a and TFPIß Maroney, S. Ellery, Paul Wood, J. Ferrel, J. Martinez, N. Mast, A. Background: Tissue factor pathway inhibitor (TFPI) is an alternatively spliced protein with two isoforms, TFPIa and TFPIß, which differ in their C-terminal structure and cellular localization. Detailed characterization of their inhibitory activity is needed to define potentially unique inhibitory roles in tissue factor (TF)-mediated thrombotic and inflammatory disease, and to understand how pharmaceuticals targeted to different structural regions of the TFPI isoforms alter hemostasis in hemophilia patients. Methods: The TF inhibitory activity of TFPIß localized to the surface of CHO cells was compared with that of soluble TFPIa by the use of in vitro and in vivo assays. Results: In TF-factor VIIa-mediated FXa generation assays, TFPIß was a slightly better inhibitor than TFPIa, which was approximately three-fold better than TFPI-160, a soluble, altered form of TFPI similar to TFPIß. In direct FXa inhibitory assays, TFPIß had an IC50 2.5-fold lower than that of TFPIa and 56-fold lower than that of TFPI-160. TFPIß inhibited TF-mediated CHO cell migration though Matrigel, whereas TFPIa and TFPI-160 were poor inhibitors, demonstrating that TFPIß effectively blocks TF-initiated signaling events during cellular migration through matrices that are not permeable to soluble forms of TFPI. Furthermore, TFPIß inhibited TF-dependent CHO cell infiltration into lung tissue following tail vein injection into SCID mice, and blocked the development of consumptive coagulopathy. Conclusions: TFPIß is a slightly better inhibitor of TF procoagulant activity than TFPIa. As a surface-associated protein, TFPIß is a much better inhibitor of TF-mediated cellular migration than soluble TFPIa, and may specifically act in the inhibition of TF-mediated signaling events on inflamed endothelium and/or monocytes. © 2013 International Society on Thrombosis and Haemostasis. 2013 Journal Article http://hdl.handle.net/20.500.11937/18059 10.1111/jth.12188 unknown
spellingShingle Maroney, S.
Ellery, Paul
Wood, J.
Ferrel, J.
Martinez, N.
Mast, A.
Comparison of the inhibitory activities of human tissue factor pathway inhibitor (TFPI)a and TFPIß
title Comparison of the inhibitory activities of human tissue factor pathway inhibitor (TFPI)a and TFPIß
title_full Comparison of the inhibitory activities of human tissue factor pathway inhibitor (TFPI)a and TFPIß
title_fullStr Comparison of the inhibitory activities of human tissue factor pathway inhibitor (TFPI)a and TFPIß
title_full_unstemmed Comparison of the inhibitory activities of human tissue factor pathway inhibitor (TFPI)a and TFPIß
title_short Comparison of the inhibitory activities of human tissue factor pathway inhibitor (TFPI)a and TFPIß
title_sort comparison of the inhibitory activities of human tissue factor pathway inhibitor (tfpi)a and tfpiß
url http://hdl.handle.net/20.500.11937/18059